Is lamotrigine (Lamictal) effective for treating major depressive disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Lamotrigine is NOT recommended for major depressive disorder

Lamotrigine lacks FDA approval and robust evidence for treating unipolar major depressive disorder, and should not be used for this indication. The available evidence shows it is FDA-approved only for bipolar disorder maintenance therapy, not for acute depression treatment 1.

Evidence from Guidelines

The American College of Physicians guidelines for treating major depressive disorder 2, 3 make no mention of lamotrigine as a treatment option. Instead, they recommend:

  • Second-generation antidepressants (SSRIs, SNRIs) or cognitive behavioral therapy as first-line treatments 2
  • Selection should be based on adverse effect profiles, cost, and patient preferences 4
  • No single second-generation antidepressant shows superior efficacy over others 4

FDA-Approved Indications

According to FDA labeling 5 and clinical guidelines 1, lamotrigine is approved for:

  • Maintenance therapy in bipolar disorder (adults) - preventing mood episodes
  • NOT approved for acute depression in either bipolar or unipolar disorder
  • The only FDA-approved combination for bipolar depression is olanzapine-fluoxetine 1

Research Evidence Shows Limited Efficacy

The highest quality research demonstrates lamotrigine's limitations in depression:

  • The largest double-blind placebo-controlled trial (N=183) failed to show statistically significant benefit when lamotrigine was added to paroxetine in treatment-resistant unipolar depression 6
  • A systematic review concluded lamotrigine has "at most small" effect in acute bipolar depression, with no evidence of effectiveness in unipolar depression 7
  • While some smaller open-label studies 8, 9, 10 suggested possible benefits as augmentation therapy, these are contradicted by the larger, better-designed placebo-controlled trial 6

Clinical Context

For unipolar major depressive disorder:

  • Start with an SSRI (sertraline, escitalopram, fluoxetine) or SNRI (venlafaxine, duloxetine) 4, 2
  • If inadequate response after 6-8 weeks, switch to another second-generation antidepressant or add cognitive behavioral therapy 4
  • Consider augmentation with evidence-based agents (not lamotrigine)

For bipolar depression:

  • Lamotrigine may have a role in maintenance/prophylaxis 1, 11
  • For acute bipolar depression, consider quetiapine, lurasidone, or olanzapine-fluoxetine combination 11

Important Safety Considerations

If lamotrigine were to be considered off-label (which is not recommended for unipolar depression), critical risks include 5:

  • Stevens-Johnson syndrome and serious rash (requires slow titration)
  • Hemophagocytic lymphohistiocytosis
  • Cardiac conduction abnormalities
  • Increased suicidal ideation risk (as with all antiepileptic drugs)

The dermatological risk alone represents a significant barrier, with 15% of psychiatrists citing it as a major prescribing limitation 12.

References

1
Guideline

practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.

Journal of the American Academy of Child and Adolescent Psychiatry, 2007

7
Research

Lamotrigine: when and where does it act in affective disorders? A systematic review.

Journal of psychopharmacology (Oxford, England), 2011

Related Questions

Would lamotrigine (Lamictal) be appropriate for a 14‑year‑old with persistent unipolar depression who is currently taking fluoxetine 20 mg daily and refusing dose escalation?
In a patient currently taking escitalopram 20 mg, is it safe to add lamotrigine 25 mg to treat mood lability and impulsivity, and what concerns or monitoring are required?
Is lamotrigine an effective first-line augmentation for unipolar depression with irritability and mood lability, and what is the appropriate dosing schedule?
In a 39-year-old female with recurrent moderate major depressive disorder, post‑traumatic stress disorder, generalized anxiety disorder, and bipolar I disorder, does the clinical note justify increasing lamotrigine from 50 mg to 100 mg daily and gabapentin from 300 mg twice daily to 300 mg three times daily?
What is the recommended medication regimen for a 43‑year‑old woman with bipolar spectrum disorder, recurrent depressive episodes, anxiety, a recent suicide attempt, and prior response to lamotrigine and sertraline, who is transitioning from residential psychiatric treatment?
What imaging is recommended for evaluating suspected cervicogenic dizziness?
What is the most likely diagnosis for a 26-year-old woman, 10 months postpartum, para 3, with generalized abdominal swelling where the umbilical area remains slightly protruded when she tries to suck in the abdomen?
Can a 37-year-old woman with several days of right ear pain radiating to the jaw and throat, a bulging tympanic membrane, mild oropharyngeal erythema, and tender right anterior cervical lymphadenopathy be treated with antibiotics alone while awaiting rapid influenza, COVID‑19, and streptococcal test results?
Is lamotrigine effective for treating depressive episodes in bipolar disorder?
Why does stress cause hair loss?
Are Breo (fluticasone propionate + salmeterol) and Breztri (budesonide + glycopyrrolate + formoterol) the same medication?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.